<div id="readability-page-1"><p>Financial Advocates Investment Management raised its holdings in  Zoetis Inc. (NYSE:ZTS - Free Report) by 81.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,273 shares of the company's stock after purchasing an additional 2,822 shares during the quarter. Financial Advocates Investment Management's holdings in Zoetis were worth $1,022,000 at the end of the most recent reporting period.</p><ul><li>Which Pet Stock Should Get Your Tail Wagging in 2024?</li></ul><p>Other hedge funds also recently added to or reduced their stakes in the company. Legacy CG LLC acquired a new position in shares of  Zoetis in the 4th quarter valued at about $4,400,000.  Bleakley Financial Group LLC raised its position in  Zoetis by 15.0% during the fourth quarter. Bleakley Financial Group LLC now owns 12,351 shares of the company's stock valued at $2,012,000 after acquiring an additional 1,612 shares in the last quarter.  YANKCOM Partnership acquired a new position in  Zoetis in the fourth quarter valued at approximately $473,000.  Tyche Wealth Partners LLC purchased a new stake in  Zoetis in the 4th quarter worth approximately $501,000.  Finally, Choreo LLC grew its stake in shares of  Zoetis by 46.5% during the 4th quarter. Choreo LLC now owns 28,408 shares of the company's stock worth $4,613,000 after purchasing an additional 9,018 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors. </p><h2>Analyst Ratings Changes</h2><p>Several research firms recently issued reports on ZTS. Stifel Nicolaus decreased their target price on shares of Zoetis from $210.00 to $180.00 and set a &#34;buy&#34; rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase &amp; Co. increased their target price on shares of Zoetis from $225.00 to $230.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, October 11th. Leerink Partners assumed coverage on Zoetis in a research report on Monday, December 2nd. They set an &#34;outperform&#34; rating and a $215.00 target price on the stock. Leerink Partnrs raised Zoetis to a &#34;strong-buy&#34; rating in a report on Monday, December 2nd. Finally, UBS Group assumed coverage on Zoetis in a report on Monday, December 9th. They issued a &#34;neutral&#34; rating and a $196.00 price objective on the stock. One analyst  has rated the stock with a hold rating, ten have given a buy rating and two have assigned  a strong buy rating to the company. Based on data from MarketBeat, Zoetis  has an average rating of &#34;Buy&#34; and a consensus target price of $215.00.</p><ul><li>MarketBeat Week in Review – 07/31 - 08/04</li></ul><p><b>Read Our Latest Analysis on ZTS</b></p><h2>Zoetis Stock Down 1.6 %</h2><p>Shares of ZTS opened at $171.37 on Friday. The stock has a 50 day moving average price of $169.34 and a 200 day moving average price of $179.28. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. The stock has a market capitalization of $77.32 billion, a price-to-earnings ratio of 32.21, a PEG ratio of 2.72 and a beta of 0.90. </p><h2>Zoetis Dividend Announcement</h2><ul><li>Rising Dividend Make Zoetis a Doggone Winner</li></ul><p>The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date is Monday, April 21st. Zoetis's dividend payout ratio (DPR) is 37.59%. </p><h2>Zoetis Company Profile</h2> (Free Report)<p>Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Zoetis</li><li>CD Calculator: Certificate of Deposit Calculator </li><li>IBM’s AI Bet Pays Off—What’s Next for Investors?</li><li>3 Fintech Stocks With Good 2021 Prospects</li><li>3 Reasons to Treat AMD's Drop as an Entry Opportunity</li><li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li><li>Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?</li></ul><p><strong>Want to see what other hedge funds are holding ZTS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Where Should You Invest $1,000 Right Now?</h2><p>Before you make your next trade, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p><p>Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p><p>They believe these five stocks are the five best companies for investors to buy now...</p><p>See The Five Stocks Here </p><h2>Should You Invest $1,000 in Zoetis Right Now?</h2><p>Before you consider Zoetis, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.</p><p>While Zoetis currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Financial Advocates Investment Management increased its stake in Zoetis Inc. (NYSE:ZTS) by 81.8% in Q4, owning 6,273 shares valued at $1,022,000. Other hedge funds also adjusted their positions, with notable increases from Legacy CG LLC and Bleakley Financial Group LLC. Analysts have mixed ratings on Zoetis, with a consensus target price of $215.00. The stock is currently down 1.6%, trading at $171.37, with a market cap of $77.32 billion. Zoetis announced a quarterly dividend of $0.50, yielding 1.17%.</p>

Financial Advocates Investment Management Raises Stock Position in Zoetis Inc. (NYSE:ZTS)